ReviewPostepy dermatologii i alergologii2026
Lebrikizumab for the treatment of atopic dermatitis: a systematic review and meta-analysis of randomised controlled trials.
Jiaxi Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.